Relationships of MMP-9, E-cadherin, and VEGF expression with clinicopathological features and response to chemosensitivity in gastric cancer

Tumor Biology

Volumn 39, Issue 5, 2017, Pages

  Gao, Hongyu ^a   Lan, Xiuwen ^a   Li, Sen ^a   Xue, Yingwei ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Chemosensitivity; Collagen gel droplet embedded culture drug sensitivity test; E cadherin; Gastric cancer; Matrix metalloproteinase 9; Vascular endothelial growth factor

Indexed keywords

GELATINASE B; OXALIPLATIN; UVOMORULIN; VASCULOTROPIN; CADHERIN; CDH1 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; PLATINUM COMPLEX; SILICATE; TITANIUM; TITANIUM SILICIDE; TUMOR MARKER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CANCER STAGING; CHEMOSENSITIVITY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; STOMACH CANCER; TUMOR INVASION; TUMOR VOLUME; ADOLESCENT; BIOSYNTHESIS; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; STOMACH NEOPLASMS;

ADOLESCENT; ADULT; AGED; BIOMARKERS, TUMOR; CADHERINS; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; SILICATES; STOMACH NEOPLASMS; TITANIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85019977291     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1177/1010428317698368     Document Type: Article

References (31)

1. Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115-132.
2. Siegel RL, Miller KD, Jemal A, et al. Cancer statistics, 2016. CA Cancer J Clin 2016; 66: 7-30.
3. Dicken BJ, Graham K, Hamilton SM, et al. Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques. Ann Surg 2006; 243: 64-73.
4. Nadauld LD and Ford JM. Molecular profiling of gastric cancer: toward personalized cancer medicine. J Clin Oncol 2013; 31: 838-839.
5. Mahale J, Smagurauskaite G, Brown K, et al. The role of stromal fibroblasts in lung carcinogenesis: a target for chemoprevention? Int J Cancer 2016; 138: 30-44.
6. Ishiyama N, Lee SH, Liu S, et al. Dynamic and static interactions between p120 catenin and E-cadherin regulate the stability of cell-cell adhesion. Cell 2010; 141: 117-128.
7. Jiang WG, Grimshaw D, Martin TA, et al. Reduction of stromal fibroblast-induced mammary tumor growth, by retroviral ribozyme transgenes to hepatocyte growth factor/ scatter factor and its receptor, c-MET. Clin Cancer Res 2003; 9: 4274-4281.
8. Ferreira P, Oliveira MJ, Beraldi E, et al. Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Exp Cell Res 2005; 310: 99-104.
9. Cavallaro U and Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-132.
10. Yoo YA, Kang MH, Lee HJ, et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 2011; 71: 7061-7070.
11. Huang S, Van Arsdall M, Tedjarati S, et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. J Natl Cancer Inst 2002; 94(15): 1134-1142.
12. Ceteci F, Ceteci S, Karreman C, et al. Disruption of tumor cell adhesion promotes angiogenic switch and progression to micrometastasis in RAF-driven murine lung cancer. Cancer Cell 2007; 12: 145-159.
13. Ahn GO and Brown JM. Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 2008; 13: 193-205.
14. Urano N, Fujiwara Y, Doki Y, et al. Overexpression of hypoxia-inducible factor-1 alpha in gastric adenocarcinoma. Gastric Cancer 2006; 9: 44-49.
15. Awazu Y, Nakamura K, Mizutani A, et al. A novel inhibitor of c-Met and VEGF receptor tyrosine kinases with a broad spectrum of in vivo antitumor activities. Mol Cancer Ther 2013; 12: 913-924.
16. Jomrich G and Schoppmann SF. Targeting HER 2 and angiogenesis in gastric cancer. Expert Rev Anticancer Ther 2016; 16: 111-122.
17. Nakahara T, Sakaeda T, Nakamura T, et al. Chemosensitivity assessed by collagen gel droplet embedded culture drug sensitivity test, and MDR1, MRP1, and MRP2 mRNA expression in human colorectal adenocarcinomas. Pharm Res 2004; 21: 406-412.
18. Naitoh H, Yamamoto H, Murata S, et al. Stratified phase II trial to establish the usefulness of the collagen gel droplet embedded culture-drug sensitivity test (CD-DST) for advanced gastric cancer. Gastric Cancer 2014; 17: 630-637.
19. Nagai N, Minamikawa K, Mukai K, et al. Predicting the chemosensitivity of ovarian and uterine cancers with the collagen gel droplet culture drug-sensitivity test. Anticancer Drugs 2005; 16: 525-531.
20. Kawamura M, Gika M, Abiko T, et al. Clinical evaluation of chemosensitivity testing for patients with unresectable nonsmall cell lung cancer (NSCLC) using collagen gel droplet embedded culture drug sensitivity test (CD-DST). Cancer Chemother Pharmacol 2007; 59: 507-513.
21. Takebayashi K, Mekata E, Sonoda H, et al. Clinical potential of the anticancer drug sensitivity test for patients with synchronous stage IV colorectal cancer. Cancer Chemother Pharmacol 2013; 72: 217-222.
22. Takamura Y, Kobayashi H, Taguchi T, et al. Prediction of chemotherapeutic response by collagen gel droplet embedded culture-drug sensitivity test in human breast cancers. Int J Cancer 2002; 98: 450-455.
23. Yu Q and Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999; 13: 35-48.
24. Wang B, Xu YF, He BS, et al. RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro. J Exp Clin Cancer Res 2010; 29: 61.
25. Srivastava RK, Kurzrock R and Shankar S. MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo. Mol Cancer Ther 2010; 9: 3254-3266.
26. Nakamura K, Kodama J, Hongo A, et al. Role of emmprin in endometrial cancer. BMC Cancer 2012; 12: 191.
27. Akdeniz O, Akduman D, Haksever M, et al. Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin. Asian Pac J Cancer Prev 2013; 14: 5301-5310.
28. McConkey DJ, Choi W, Marquis L, et al. Role of epithelial-tomesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009; 28: 335-344.
29. Ma L, Young J, Prabhala H, et al. miR-9, a MYC/MYCNactivated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010; 12: 247-256.
30. Derksen PW, Liu X, Saridin F, et al. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006; 10: 437-449.
31. Ilson DH. Docetaxel, cisplatin, and fluorouracil in gastric cancer: does the punishment fit the crime? J Clin Oncol 2007; 25: 3188-3190.